Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Simonelli

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
International Journal of Molecular Sciences|October 14, 2023
Analytical Ultracentrifugation Detects Quaternary Rearrangements and Antibody-Induced Conformational Selection of the SARS-CoV-2 Spike TrimerGiuditta Guerrini, Dora Mehn, Francesco Fumagalli, et al.
Journal of Medicinal Chemistry|September 13, 2021
Systematic Development of Peptide Inhibitors Targeting the CXCL12/HMGB1 InteractionJacopo Sgrignani, Valentina Cecchinato, Enrico M A Fassi, et al.
Plos Pathogens|October 2, 2018
A bispecific immunotweezer prevents soluble PrP oligomers and abolishes prion toxicityMarco Bardelli, Karl Frontzek, Luca Simonelli, et al.
Global Challenges (Hoboken, NJ)|October 13, 2023
Adapting Neutralizing Antibodies to Viral Variants by Structure-Guided Affinity Maturation Using Phage Display TechnologyFrederik Peissert, Mattia Pedotti, Riccardo Corbellari, et al.
Journal of Virology|December 4, 2024
Ultrapotent IgA dimeric antibodies neutralize emerging Omicron variantsFanglei Zuo, Yunlong Cao, Rui Sun, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 28, 2021
Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational studyIrene Cassaniti, Federica Bergami, Elena Percivalle, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 29, 2015
Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirusDavide Corti, Jincun Zhao, Mattia Pedotti, et al.
Cell Host & Microbe|September 14, 2010
The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activityMartina Beltramello, Katherine L Williams, Cameron P Simmons, et al.
Emerging Microbes & Infections|November 25, 2024
Discovery of a pan anti-SARS-CoV-2 monoclonal antibody with highly efficient infected cell killing capacity for novel immunotherapeutic approachesDaouda Abba Moussa, Mario Vazquez, Christine Chable-Bessia, et al.
Nature Structural & Molecular Biology|August 10, 2022
A conformational switch controlling the toxicity of the prion proteinKarl Frontzek, Marco Bardelli, Assunta Senatore, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|October 14, 2023
Analytical Ultracentrifugation Detects Quaternary Rearrangements and Antibody-Induced Conformational Selection of the SARS-CoV-2 Spike TrimerGiuditta Guerrini, Dora Mehn, Francesco Fumagalli, et al.
Journal of Medicinal Chemistry|September 13, 2021
Systematic Development of Peptide Inhibitors Targeting the CXCL12/HMGB1 InteractionJacopo Sgrignani, Valentina Cecchinato, Enrico M A Fassi, et al.
Plos Pathogens|October 2, 2018
A bispecific immunotweezer prevents soluble PrP oligomers and abolishes prion toxicityMarco Bardelli, Karl Frontzek, Luca Simonelli, et al.
Global Challenges (Hoboken, NJ)|October 13, 2023
Adapting Neutralizing Antibodies to Viral Variants by Structure-Guided Affinity Maturation Using Phage Display TechnologyFrederik Peissert, Mattia Pedotti, Riccardo Corbellari, et al.
Journal of Virology|December 4, 2024
Ultrapotent IgA dimeric antibodies neutralize emerging Omicron variantsFanglei Zuo, Yunlong Cao, Rui Sun, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 28, 2021
Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational studyIrene Cassaniti, Federica Bergami, Elena Percivalle, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 29, 2015
Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirusDavide Corti, Jincun Zhao, Mattia Pedotti, et al.
Cell Host & Microbe|September 14, 2010
The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activityMartina Beltramello, Katherine L Williams, Cameron P Simmons, et al.
Emerging Microbes & Infections|November 25, 2024
Discovery of a pan anti-SARS-CoV-2 monoclonal antibody with highly efficient infected cell killing capacity for novel immunotherapeutic approachesDaouda Abba Moussa, Mario Vazquez, Christine Chable-Bessia, et al.
Nature Structural & Molecular Biology|August 10, 2022
A conformational switch controlling the toxicity of the prion proteinKarl Frontzek, Marco Bardelli, Assunta Senatore, et al.
Pageof 4